Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. [PDF]
PLoS Medicine, 2018 BackgroundMultimorbidity is increasingly common and is associated with adverse health outcomes, highlighting the need to broaden the single-disease framework that dominates medical research.
Archana Singh-Manoux +6 more
doaj +2 more sources
Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study [PDF]
The Lancet. Healthy Longevity, 2022 Summary: Background: Individual cardiometabolic disorders and genetic factors are associated with an increased dementia risk; however, the relationship between dementia and cardiometabolic multimorbidity is unclear.
Xin You Tai, MBBS +7 more
doaj +3 more sources
Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe [PDF]
The Lancet Public Health, 2017 Summary: Background: Although overweight and obesity have been studied in relation to individual cardiometabolic diseases, their association with risk of cardiometabolic multimorbidity is poorly understood.
Mika Kivimäki, ProfPhD +29 more
doaj +3 more sources
Trends in cardiometabolic multimorbidity in non-elderly adult Medicaid enrollees, 2018–2022 [PDF]
Frontiers in EpidemiologyImportanceMedicaid, as the largest U.S. insurer, can reduce cardiometabolic multimorbidity.ObjectiveAssess patterns and trends in cardiometabolic multimorbidity among Medicaid-enrolled adults.DesignAnalysis of 2018–2022 National Health Interview Survey ...
Puneet Kaur Chehal +4 more
doaj +2 more sources
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) [PDF]
Cardiovascular Diabetology, 2020 Background Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity.
Ernesto Maddaloni +16 more
doaj +3 more sources
Temporal change in multimorbidity prevalence, clustering patterns, and the association with mortality: findings from the China Kadoorie Biobank study in Jiangsu Province [PDF]
Frontiers in Public HealthObjectivesThe characteristics of multimorbidity in the Chinese population are currently unclear. We aimed to determine the temporal change in multimorbidity prevalence, clustering patterns, and the association of multimorbidity with mortality from all ...
Hao Yu +21 more
doaj +3 more sources
Employment status and cardiometabolic multimorbidity: results from China health and retirement longitudinal study [PDF]
Population Health MetricsGlobally, cardiometabolic diseases (CMDs) are major health issues that affect the health of workforce. This study aimed to investigate the impact of employment status on transition from a healthy state to cardiometabolic multimorbidity in Chinese ...
Yuwei Pan +3 more
doaj +2 more sources
Frontiers in Cardiovascular Medicine, 2023 ObjectiveIn China, a limited number of studies focus on women and examine the effect of cardiometabolic multimorbidity (defined as the presence of two or more cardiometabolic diseases) on health outcomes.
Yang Zhao +11 more
doaj +1 more source
Cardiovascular Diabetology, 2022 Objective To assess trends in primary and specialist care consultation rates and average length of consultation by cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), or cardiometabolic multimorbidity exposure status.
Sophia Abner +8 more
doaj +1 more source
Global Heart, 2023 Background: Integrated management of cardiometabolic diseases is crucial in improving the quality of life of older persons. The objective of the study was to identify clusters of cardiometabolic multimorbidity associated with moderate and severe ...
Peter Otieno +7 more
doaj +1 more source